1.Last, R.J. (1991).Anatomy Regional and Applied.
Edinburgh Churchill Livingstone. 331-333.
2..Moore, K., Dalley, A. (1999). Clinically oriented
Anatomy. Baltimore, Maryland: Lippincott
Williams and Wilkins 30: 186-197.
3.Boyle, P., Zandze,D.G. (2003). Risk factors for
prostate and testicular cancer. EuropeanJournal of
cancer29:1048-1055.
4.Steive, H. (1990). Mannliche Genitalorgane.
Handbuch der mikroskopischen Anatomie des
Menschen. Vol VII Part2. Berlin: Springer. 1-399.
5.Diamoandis, E.P. (1998). Prostate specific antigen:
its usefulness in clinical
medicine. Trends in Endocrinology 8: 310-316.
6.Hara, M., Koyanagi, Y., Inoue, T., Fukuyana,
T.(1971). An antigenic component specific for
human seminal plasma.Journal of American Medical
Association 25: 322-324.
7.Catalona, W., Partin, A., Slawin, K., Brawer, M.,
Flanigan, R., Patel, A., Richie, J., deKernion, J.,
Walsh, P., Scardino, P., Lange, P., Subong, E.,
Parson, R., Gasior,. G, Loveland, K., Southwick, P.
(1998). Use of the percentage of free prostatespecific
antigen to enhance differentiation of prostate
cancer from benign prostatic disease: a prospective
multicenter clinical trial. Journal of American
Medical Association 279 (19): 1542–1547.
8.Pienta, K.J. (2008).Etiology,Epidermiology and
Prevention of Carcinoma of the prostate.
Campbell Urology 7thedition. 2487-2495.
9.Brawley, O.W. (2007) prostate carcinoma
incidence and patients mortality: the effect of
screening and early detection. Cancer80:1857-1863.
10.Jemal, A., Siegel, R., Ward, E. (2008). Cancer
Statistics. Cancer Journal.58:71–96.
11. Lawani, J., Nkposong, E.C., Aghadiuno, P.U.
(1985). Urologic tumors of the genitaourinary
tract. Cancer in Nigeria, Ibadan University press 20:
67-74.
12.Signorello, L.B., Adami, H.O., Hunter, D.,
Trichopoulos, D.(2002). Prostate Cancer.
Textbook of Cancer Epidemiology. Oxford University
Press; 44: 62-67.
13.Whitmore, W.E. (1994). Natural history and
stages of prostate carcinoma. Urologic clinics
of cancer 10: 22-34.
14.Tanya, E., Pollard, H., Allen, F., Roberts T.
(2006). The Pleasures and Perils of Smoking in Early
Modern England in Smoke. 7:36-38.
15.Stellman, S.D., Djordjevic, M.V. (2009).
Monitoring the tobacco use epidemic II: The
agent: Current and emerging tobacco products.
Preventive Medicine. 48(1 Suppl): S11-15.
16.Adamopoulos D, Argacha JF, Gujic M, Preumont
N, Degaute JP, van de Borne P. (2009) Acute
effects of nicotine on arterial stiffness and wave
reflection in healthy young non-smokers.
Clinical Experiment PharmacologicalPhysiology
36(8): 784–789.
17.West, R. and Shiffman, S. (2007). Fast Facts:
Smoking Cessation. Health Journal. 20:28.
18.Nyboe, J., Jensen, G., Appleyard, M., Schnohr, P.
(2009). Risk factors for acutemyocardial infarction in
Copenhagen. I: Hereditary, educational and
socioeconomic factors. Copenhagen City Heart
Study. European Heart Journal.10 (10): 910–916.
19.Devereux G. (2006). ABC of chronic obstructive
pulmonary disease- Definition,epidemiology, and
risk factors.British Medical Journal.332:1142-1144.
20.Matthew Hilton., Eysenck, H. J. (2006) Smoking
and Sociability in Smoke.19:133.
Indian Journal of Basic and Applied Medical Research; March 2015: Vol.-4, Issue- 2, P. 172-183
181
www.ijbamr.com P ISSN: 2250-284X , E ISSN : 2250-2858
21.Cataldo. J., Prochaska, J., Glantz, S. (2010).
Cigarette Smoking is a Risk Factor for Alzheimer's
Disease: an Analysis Controlling for Tobacco
Industry Affiliation. Journal of Alzheimer's disease:
Journal of American Diseases.19 (2): 465–480.
22.Cosnes, J. (1999). Effects of current and former
cigarette smoking on the clinical course of Crohn's
disease. Aliment Pharmacology Ther.13 (11): 1403–
1411.
23.Gilman, Sander L. and Xun, Zhou (2004).
Introduction in Smoke: A Global History of
Smoking. Smoke.Reaktion Books. p. 20–22.
24.Anetor, J. I., Ajose, F., Anetor, G. O., Iyanda, A.
A., Babalola O. O., Adeniyi, F. A. A. (2008)
High Cadmium / Zinc Ratio In Cigarette Smokers:
Potential Implications As A Biomarker Of Risk Of
Prostate Cancer. Nigerian Journal Of Physiological
Sciences Vol. 23, No. 1-2, pp. 41-49.
25 .Stamey, T.A., Yang, N., Hay,A.R.(1991).Prostate
specific antigen as a serum marker for
adenocarcinoma of the prostate. The New England
Journal of Medicine. 317: 909-916.
26.Catalona, W. J., Richie, J. P., Ahmann, F. R.,
Hudson, M. A., Scardino, P. T., Flanigan, R. C.,
Dekernion, J. B., Ratliff, T. L. (1994). Comparison of
digital rectal examination and serum prostate specific
antigen in the early detection of prostate
cancer: Results of a multicenter clinical trial of 6,630
men. The Journal of urology151 (5): 1283–1290.
27.Siegel, R, (2011). Cancer statistics 2011: the
impact of eliminating socioeconomic and
racial disparities on premature cancer deaths. Cancer
Journal of Clinicans.61: 212–36.
28.Baade, P.D.; Youlden, D.R.; Krnjacki, L.J. (2009).
International epidemiology of prostate cancer:
geographical distribution and secular trends.
MolecularNutrition & Food Research53 (2): 171–
184.
29.Kristal, A.R., Chi, C., Tangen, C.M., Goodman,
P.J., Etzioni, R. (2006) Thompson, I.M. Associations
of demographic and lifestyle characteristics with
prostate- specific antigen (PSA) concentration and
rate of PSA increase. Cancer. 106:320–328.
30.Li,J.,Trevor, T., Djenaba, J., Viraj, M. (2012)
Association Between Smoking Status And Free,
Total, And Percent Free Prostate-Specific Antigen
The Journal of Urology. Volume 187 Issue 4,
Supplement,e 894.
31.Giovannucci, E., Liu, Y., Platz, E.A., Stampfer,
M.J., Willett, W.C. (2007) Risk factors for
prostate cancer incidence and progression in the
health professionals follow-up study. International
Journal of Cancer121: 1571- 1578.
32.Rohrmann, S., Linseisen, J., Allen, N., Bueno-de-
Mesquita, H. B., Johnsen, N. F., Tjønneland, A., Key,
T. J. (2013). Smoking and the risk of prostate cancer
in the .European Prospective Investigation into
Cancer and Nutrition. British Journalof
Cancer108(3):708-714.
33.Roddam, A.W., Allen, N.E., Appleby, P. (2008)
Insulin-like Growth Factors, Their Binding Proteins,
and Prostate Cancer Risk: Analysis of Individual
Patient Data from 12 Prospective Studies. Annals
International Medicine.149:461– 471.
34.Renehan, A.G., Atkin, W.S., O'Dwyer, S.T.,
Shalet, S.M. (2004). The effect of cigarette smoking
use and cessation on serum insulin-like growth
factors. Brooklyn Journal of Cancer.91:1525–1531.
35.Zwahlen,M., Renehan, A.G., Minder, C.,
O'Dwyer, S.T., Shalet, S.M., Egger, M. (2004).
Insulin-like growth factor (IGF)-I, IGF binding
protein-3, and cancer risk: systematic review
Indian Journal of Basic and Applied Medical Research; March 2015: Vol.-4, Issue- 2, P. 172-183
182
www.ijbamr.com P ISSN: 2250-284X , E ISSN : 2250-2858
and meta-regression analysis. Lancet.363:1346–
1353.
36.Field, A.E., Colditz, G.A., Willett, W.C.,
Longcope, C., McKinlay, J.B. (1994). The
relation of smoking, age, relative weight, and dietary
intake to serum adrenal steroids, sex hormones, and
sex hormone-binding globulin in middle-aged
men. Journal of Clinical Endocrinology
Metabolism.79:1310– 1316.
37.Gann, P.H., Hennekens, C.H., Ma, J., Longcope,
C., Stampfer,
J.(1996)ProspectiveStudyofSex Hormone Levels and
Risk of Prostate Cancer. Journal of
National Cancer Institute.88:1118–1126.
38.Meigs, J.B., Mohr, B., Barry, M.J., Collins, M.M.,
McKinlay, J.B. (2001) Risk factorsfor clinical
benign prostatic hyperplasia in a community-based
population of healthy aging men. Journal of Clinical
Epidemiology.54:935–944.
39.Platz, E.A., Rimm, E.B., Kawachi, I. (1999)
Alcohol Consumption, Cigarette Smoking, and
Risk of Benign Prostatic Hyperplasia. American
Journal of Epidemiology.149:106–115.
40.Singer, E.A., Palapattu, G.S., van Wijngaarden,
G.S. (2008) Prostate-specific antigen levels in
relation to consumption of nonsteroidal antiinflammatory
drugs and acetaminophen.
Cancer.113:2053–2057.
41.Huncharek, M., Haddock, K.S., Reid, R.,
Kupelnick, B. (2010) Smoking as a risk factor
for prostate cancer: a meta-analysis of 24 prospective
cohort studies. American Journal of Public Health.
100:693-701.
42.Gong, Z., Agalliu, I., Lin, D.W., Stanford, J.L.,
Kristal, A.R. (2008) Cigarette smoking and
prostate cancer- specific mortality following
diagnosis in middle-aged men. Cancer Causes
Control19: 25-31.
43.Plaskon,L. A., Penson, D. F., Vaughan, T. L.,
StanfordJ. L. (2003) Cigarette Smoking and
Risk of Prostate Cancer in Middle-Aged
Men1.Cancer EpidemiologyBiomarkers
Prevention12: 604.
44.Ferrini, R. L., Barrett-Connor, E. (1998) Sex
hormones and age: a cross-sectional study of
testosterone and estradiol and their bioavailable
fractions in community-dwelling men.
American Journal Epidemiology. 147: 750-754.
45.Kupeli, B., Soygur, T., Aydos, K., Ozdiler, E.,
Kupeli, S. (1997) The role of cigarette smoking
in prostatic enlargement. British Journal of Urology.
80: 201-204.
46.Koskimaki, J., Hakama, M., Huhtala, H.,
Tammela, T. L. (1998) Association of smoking with
lower urinary tract symptoms. Journal of
Urology.159: 1580-1582.
47.Carter, B. S., Carter, H. B., Isaacs, J. T. (1990)
Epidemiologic evidence regarding predisposing
factors to prostate cancer. Prostate16: 187-197.
48.Zaridze, D. G., Boyle, P. (1987) Cancer of the
prostate: epidemiology and aetiology. British
Journal of Urology.59: 493-502.
49.Carroll, K. K., Noble, R. L. (1987) Dietary fat in
relation to hormonal induction of mammary and
prostatic carcinoma in Nb rats. Carcinogenesis
(London) 8: 851-853.
50.Nomura, A., Heilbrun, L. K., Stemmermann, G.
N., Judd H. L. (1988) Prediagnostic serum
hormones and the risk of prostate cancer?. Cancer
Research. 48: 3515-3517.
51.Kalcher, K., Kern, W., Pietsch, R. (1993)
Cadmium and lead in the smoke of a filter cigarette.
Scientific Total Environment. 128: 21-35.
Indian Journal of Basic and Applied Medical Research; March 2015: Vol.-4, Issue- 2, P. 172-183
183
www.ijbamr.com P ISSN: 2250-284X , E ISSN : 2250-2858
52.Saldivar, L., Luna, M., Reyes, E., Soto, R.,
Fortoul, T. I. (1991) Cadmium determination in
Mexican-produced tobacco. Environmental Research.
55: 91-96.
53.Yeargan, R., Maiti, I. B., Nielsen, M. T., Hunt, A.
G., Wagner, G. J. (1992) Tissue partitioning of
cadmium in transgenic tobacco seedlings and field
grown plants expressing the mouse metallothionein
I gene. Transgenic Research. 1: 261-267.
54.Ye, J., Wang, S., Barger, M., Castranova, V., Shi,
X. (2000) Activation of androgen response
element by cadmium: a potential mechanism for a
carcinogenic effect of cadmium in the prostate.
Journal of Environment Pathology, Toxicology
and Oncology. 19: 275-280.
55.Waalkes, M. P. (2000) Cadmium carcinogenesis
in review. Journal Inorganic Biochemistry. 79: 241-
244.
56.Watters, J.L., Park, Y., Hollenbeck, A., Schatzkin,
A., Albanes, D. (2009) Cigarette smoking and
prostate cancer in a prospective US cohort study.
Cancer Epidemiology Biomarkers Prevention18:
2427-2435.
57.Partin, A.W., Catalona, W.J., Southwick, P.C.
(1996) Analysis of percent free prostate-specific
antigen (PSA) for prostate cancer detection: influence
of total PSA, prostate volume, and age .
Urology.48:55
58.Anderson, J.R., Strickland, D., Corbin, D. (1995).
Age-specific reference ranges for serum prostate-
specific antigen. Urology. 46:54–57.
59.Algotar,A. M.,Stratton, S. P., Ranger-Moore, J.,
Suzanne Stratton, M., Hsu, C.H.,Ahmann, F.
R., Nagle, R.B., Thompson P. A. (2010). Association
of Obesity and Smoking With PSA and PSA Velocity
in Men With Prostate Cancer. Prostate.70:883.
60.Loeb, S., Nadler, R.B., Roehl, K.A. (2007) Risk of
prostate cancer for young men with a prostate
specific antigen less than their age specific median.
Journal of Urology .177:1745.
61.Hickey, K., Donki, K.A., Green, A. (2001).
Smoking and Prostate Cancer. Epidemiology
Revised.23:115–125.
Thank you for copying data from http://www.arastirmax.com
